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Assessing the Multidimensional Relationship Between Medication Beliefs and 
Adherence in Older Adults With Hypertension Using Polynomial Regression 
Abstract 
Background: The Necessity–Concerns Framework (NCF) is a multidimensional theory describing the 
relationship between patients’ positive and negative evaluations of their medication which interplay to 
influence adherence. Most studies evaluating the NCF have failed to account for the multidimensional 
nature of the theory, placing the separate dimensions of medication “necessity beliefs” and “concerns” 
onto a single dimension (e.g., the Beliefs about Medicines Questionnaire–difference score model). 
Purpose: To assess the multidimensional effect of patient medication beliefs (concerns and necessity 
beliefs) on medication adherence using polynomial regression with response surface analysis. 
Methods: Community-dwelling older adults >65 years (n = 1,211) presenting their own prescription for 
antihypertensive medication to 106 community pharmacies in the Republic of Ireland rated their concerns 
and necessity beliefs to antihypertensive medications at baseline and their adherence to antihypertensive 
medication at 12 months via structured telephone interview. 
Results: Confirmatory polynomial regression found the difference-score model to be inaccurate; 
subsequent exploratory analysis identified a quadratic model to be the best-fitting polynomial model. 
Adherence was lowest among those with strong medication concerns and weak necessity beliefs, and 
adherence was greatest for those with weak concerns and strong necessity beliefs (slope β = −0.77, p 
Conclusion: Results extend evidence supporting the use of polynomial regression to assess the 
multidimensional effect of medication beliefs on adherence. 
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Model 1  β  95% CI  p‐value  R2 
   BMQ‐Specific  Score Difference  0.196  0.128‐0.264  <0.001  0.0276 
Model 2         
   BMQ‐Specific Concerns  ‐0.280  ‐0.382 to ‐0.178  <0.001  0.0314 

















BMQ Specific Concerns  ‐0.55  ‐0.79 to ‐0.33 <0.001 ‐0.56 ‐0.80 to ‐0.33  <0.001
BMQ Specific Necessity  0.24  0.05 to 0.44 0.016 0.21 0.01 to 0.41  0.046
BMQ Concerns Squared term  ‐0.17  ‐0.29 to ‐0.05 0.006 ‐0.21 ‐0.34 to ‐0.09  0.001
Interaction term  0.02  ‐0.05 to 0.10  0.549  0.01  ‐0.07 to 0.08  0.877 
BMQ Necessity Squared term   ‐0.06  ‐0.15 to 0.03 0.217 ‐0.05 ‐0.14 to 0.05  0.340
Age   0.01  0.00 to 0.02 0.033 0.01 ‐0.01 to 0.01  0.582































































Current Smoker  ‐0.20  ‐0.42 to 0.02 0.074 ‐0.12 ‐0.35 to 0.11  0.309
Heart Attack   ‐0.17  ‐0.34 to 0.01 0.053 ‐0.10 ‐0.30 to 0.10  0.310
Angina   ‐0.09  ‐0.26 to 0.09 0.321 0.07 ‐0.13 to 0.27  0.505
Stroke   ‐0.14  ‐0.46 to 0.18 0.397 ‐0.02 ‐0.35 to 0.33  0.933
No. of comorbidities   ‐0.04  ‐0.08 to ‐0.002 0.038 ‐0.07 ‐0.12 to ‐0.02  0.006
No. of regular medication  0.02  0.00 to 0.03 0.062 0.04 0.02 to 0.06  <0.001
Medication repackaged in MDU  ‐0.27  ‐0.47 to ‐0.08 0.006 ‐0.29 ‐0.51 to ‐0.07  0.010
AHT Dosing Frequency   0.05  ‐0.13 to 0.23 0.863 0.03 ‐0.16 to 0.22  0.740
AHT Defined Daily Dose  0.00  ‐0.03‐0.02 0.784 0.02 ‐0.02 to 0.06  0.322
Angiotensin Agents  0.02  ‐0.12 to 0.16 0.796 ‐0.04 ‐0.20 to 0.12  0.603
Alpha‐Blockers   ‐0.03  ‐0.27 to 0.21 0.798 ‐0.15 ‐0.41 to 0.12  0.272
Beta‐Blockers  0.03  ‐0.09 to 0.14 0.664 ‐0.02 ‐0.12 to 0.15  0.810
Calcium Channel Blockers 0.01  ‐0.11 to 0.13 0.863 ‐0.02 ‐0.16 to 0.12  0.778
Diuretics   0.08  ‐0.05 to 0.21 0.245 0.01 ‐0.15 to 0.14  0.956
GMS=General Medical Services, GP=General Practitioner, MDU=Multiple Dose Units, AHT=antihypertensive. 
The unadjusted coefficients for the BMQ‐Specific Concerns and Necessity subscale polynomial terms are 
representative of the five quadratic terms entered jointly to a null model. Missing data (participants): BMQ 
(66); Age (9); Education (60); Health Cover (22); Smoker (6); Medical History (3); Drug History (18). The 
adjusted model is a complete case analysis, which resulted in 13.6% of missing observations. To account for 
the potential biases in estimates and standard errors due to missing data, multiple imputation, with 
multivariate normal distribution, Markov Chain Monte Carlo procedure and 100 imputations was performed, 
but did not change the overall conclusions. This data has been presented as supplementary information. 
Permission to use the MMAS scales is required.  Reproduction and distribution of the MMAS is protected by 
US copyright laws.  A license agreement to use the scale is available from: Donald E. Morisky, ScD, ScM, MSPH, 
Professor, Department of Community Health Sciences, UCLA School of Public Health, 650 Charles E. Young 
Drive South, Los Angeles, CA 90095‐1772, dmorisky@gmail.com.   
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Figures	 	
Refused (n=639) 
Ineligible (n=28) (<65 years, no AHT meds) 
Completed Baseline Interview 
(n=1,564) 
Completed Follow‐up Interview 
(n=1,232) 
No consent to re‐contact (n=17) 
Lost to follow‐up (n=315) 
 Deceased (n=28) 
 Nursing home (n=9) 
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Enrolment 
Figure 1  
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